Suchergebnisse - "Blauvelt, Andrew"

PubPharm (443)

1

Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies

enthalten in: Dermatology and therapy | 2024

von Armstrong, A. | González-Cantero, A. | Khattri, S. | +7

2

Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis : A randomized, double-blinded, vehicle-controlled, phase 3 trial

enthalten in: Journal of the American Academy of Dermatology | 2024

von Blauvelt, A. | Draelos, Z. | Stein Gold, L. | +18

3

Deucravacitinib in plaque psoriasis : 2-year safety and efficacy results from the phase III POETYK trials

enthalten in: The British journal of dermatology | 2024

von Lebwohl, M. | Warren, R. | Sofen, H. | +12

CommentIn: Br J Dermatol. 2024 Feb 26;:. - PMID 38407434

4

Targeting IL-13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years

enthalten in: Allergy | 2024

von Guttman-Yassky, E. | Kabashima, K. | Staumont-Salle, D. | +10

5

Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies

enthalten in: Dermatology and therapy | 2024

von Armstrong, A. | González-Cantero, A. | Khattri, S. | +7

6

Deucravacitinib in moderate-to-severe plaque psoriasis : Pooled safety and tolerability over 52 weeks from two phase 3 trials (POETYK PSO-1 and PSO-2)

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Strober, B. | Blauvelt, A. | Warren, R. | +12

7

Mental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab : Analysis of phase 2/3 randomized trials

enthalten in: Journal of the American Academy of Dermatology | 2024

von Blauvelt, A. | Armstrong, A. | Merola, J. | +6

8

Deucravacitinib, a selective, allosteric tyrosine kinase 2 inhibitor, in scalp psoriasis : A subset analysis of two phase 3 randomized trials in plaque psoriasis

enthalten in: Journal of the American Academy of Dermatology | 2024

von Blauvelt, A. | Rich, P. | Sofen, H. | +11

9

Rapid resolution of guttate psoriasis without recurrence for one year following two doses of guselkumab

enthalten in: International journal of dermatology | 2024

von Abbad-Jaime de Aragón, C. | Berna-Rico, E. | Jaén, P. | +2

10

Reanalysis Following Removal of Participants From 1 Site in Multicenter Trial of Upadacitinib vs Dupilumab for Atopic Dermatitis

enthalten in: JAMA dermatology | 2024

von Blauvelt, A.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[45]